kezar life sciences stock

As of May 05 2022 Kezar Life Sciences Inc had a 4204 million market capitalization compared to the Biotechnology Medical Research median of 1216 million Kezar Life Sciences Incs stock is down 623 in 2022 down 469 in the previous five trading days and up 173 in the past year. The big gain came after the company announced interim results on Monday from a phase.


What Is The Ownership Structure Like For Kezar Life Sciences Inc Nasdaq Kzr

Kezar Life Sciences Inc.

. KZR stock news and headlines to help you in your trading and investing decisions. View Kezar Life Sciences Inc KZR investment stock information. 4000 Shoreline Court Suite 300 South San Francisco CA 94080 T.

Find real-time KZR - Kezar Life Sciences Inc stock quotes company profile news and forecasts from CNN Business. Today Kezar Life Sciences Inc NASDAQKZR lost 041 to end the day Thursday at 549. Kezar Life Sciences Inc 631 014 217 Watch.

The Price to Earnings PE ratio a key valuation measure is calculated by dividing the stocks most recent. Get the latest Kezar Life Sciences Inc. Stock news by MarketWatch.

KZR During the last month 5 analysts gave the Kezar Life Sciences Inc. Common Stock KZR Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. KZR stock quote history news and other vital information to help you with your stock trading and investing.

According to the issued ratings of 3 analysts in the last year the consensus rating for Kezar Life Sciences stock is Buy based on the current 3 buy ratings for KZR. KZR is higher by 024 from the previous closing price of 575 on volume of 1050723 shares. KZR stock price quote stock graph news analysis.

KZR Complete Kezar Life Sciences Inc. KZR traded up 022 on Friday reaching 574. Real-time trade and investing ideas on Kezar Life Sciences Inc KZR from the largest community of traders and investors.

Shares of Kezar Life Sciences KZR -292 were soaring 361 as of 1103 am. 4000 Shoreline Court Suite 300 South San Francisco CA 94080. Rooms Shows Rankings Earnings Newsletters Shop.

View real-time stock prices and stock quotes for a full financial overview. Kezar Life Sciences has a 1 year low. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools.

A BUY rating 0 of the polled analysts branded the stock as an OVERWEIGHT 0 analysts were recommending to HOLD this stock 0 of them gave the stock UNDERWEIGHT rating and 0 of the polled analysts provided SELL rating. Get the latest Kezar Life Sciences Inc KZR detailed stock quotes. The companys fifty day moving average price is 1350 and its 200 day moving average price is 1335.

NASDAQKZR traded at 663 at close of the session on Tuesday 051722 made an upward move of 1013 on its previous days price. Visit The Official Edward Jones Site. On average they anticipate Kezar Life Sciences stock price to reach 1667 in the next year.

Kezar Life Sciences Inc. Learn about Kezar Life Sciences Inc KZRXNAS stock quote with Morningstars rating and analysis and stay up to date with the current news price valuation dividends and other stock information. Find the latest Kezar Life Sciences Inc.

Their forecasts range from 1400 to 2200. A high-level overview of Kezar Life Sciences Inc. The average twelve-month price target for Kezar Life Sciences is 1667 with a high price target of 2200 and a low price target of 1400.

No significant news for KZR in the past two years. 44944 shares of the stock were exchanged compared to its average. Find A Dedicated Financial Advisor.

Looking at the stock we see that its previous close was 602 and the beta 5Y monthly reads 027 with the days price range being 611 6655. Over the past year the SP 500 is lower by -346 while KZR is higher by 931. Latest Kezar Life Sciences Inc KZR Stock News.

Real time Kezar Life Sciences Inc. Lets Partner Through All Of It. Kezar Life Sciences Inc KZR stock has risen 417 while the SP 500 has fallen -011 as of 121 PM on Monday May 16.

Kezar Life Sciences stock opened at 602 on Friday. The company opened at 594 and shares fluctuated between 607 and 549 with 1656088 shares trading hands. Kezar Life Sciences Inc NASDAQKZR 574.

3 brokers have issued 12-month price targets for Kezar Life Sciences shares. New Look At Your Financial Strategy. Market experts do have their say about Kezar Life Sciences Inc.

Kezar Life Sciences NASDAQKZR - Get Rating posted its quarterly earnings data on ThursdayThe company reported 026 earnings per share for the quarter topping analysts consensus estimates of 028 by 002 MarketWatch Earnings reports. Life Is For Living. Kezar Life Sciences Inc.

Kezar Life Sciences Inc Registered Shs Stock KZR. News Kezar Life Sciences IncKZR. Learn more on KZRs analyst rating history.

Finally HC Wainwright lifted their price objective on shares of Kezar Life Sciences from 2000 to 2200 and gave the stock a buy rating.


Kazar Life Sciences Stock Soars 73 On Results Of Lupus Trial San Francisco Business Times


Kezar Life Sciences Announces Pricing Of Initial Public Offering


Kezar Life Sciences Crunchbase Company Profile Funding


Why Kezar Life Sciences Stock Is Soaring Today Nasdaq


We Re Not Very Worried About Kezar Life Sciences Nasdaq Kzr Cash Burn Rate Simply Wall St News


Kzr Institutional Ownership Kezar Life Sciences Inc Nasdaq Stock


Kezar Life Sciences Targeting The Immunoproteasome To Treat Autoimmunity Nasdaq Kzr Seeking Alpha


News Events Kezar Life Sciences Inc Kzr


Kezar Life Sciences Kzr Investor Presentation Slideshow Nasdaq Kzr Seeking Alpha


Could The Kezar Life Sciences Inc Nasdaq Kzr Ownership Structure Tell Us Something Useful


Should You Buy Kezar Kzr Ahead Of Earnings


Kzr Stock Price And Chart Nasdaq Kzr Tradingview


Kezar Life Sciences Prepares For U S Ipo Nasdaq Kzr Seeking Alpha


Health Check How Prudently Does Kezar Life Sciences Nasdaq Kzr Use Debt


Why Kezar Life Sciences Shares Are Getting Hammered Benzinga


Kezar Life Sciences Inc Share Price Usd0 001


Kezar Life Sciences Key Catalysts Ahead Nasdaq Kzr Seeking Alpha


Kezar Life S Lead Asset Fails To Top Placebo In Muscle Inflammation Disease


Kezar Life Sciences Crashes After Setback To Lead Asset In Mid Stage Trial Nasdaq Kzr Seeking Alpha

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel